Wegovy

Wegovy is the higher-dose semaglutide formulation FDA-approved specifically for chronic weight management — same molecule as Ozempic, branded for the obesity market. Novo Nordisk added oral Wegovy (the pill version) in 2025, and the OASIS-4 trial supports a future sleep apnea indication. Our Wegovy coverage tracks real cash pricing, the oral vs injection tradeoffs, and dosing escalation.

Ozempic, Wegovy, Mounjaro, Zepbound: Which Wins?

Four brand names, two active drugs, and a lot of confusion. This 2026 comparison sorts Ozempic, Wegovy, Mounjaro and Zepbound…

Latest in Wegovy

Wegovy Without Insurance: How to Cut the Cost

Wegovy's list price is about $1,350 a month — but in 2026 that number tells you almost nothing about what…

Compounded Semaglutide from $147/month

LegitScript-certified · 503A US pharmacy · 1-2 day shipping · Available in 48 states

More from Wegovy